Measured Wealth Private Client Group’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$64.5K Sell
749
-134
-15% -$12K 0.02% 266
2025
Q4
$77.1K Sell
883
-54
-6% -$4.1K 0.02% 267
2025
Q3
$53.7K Buy
+937
New +$54K 0.01% 293

Other funds holding GMED

Measured Wealth Private Client Group's GMED Position: Q1 2026 in Review

Measured Wealth Private Client Group reduced its Globus Medical (GMED) stake by 15% in Q1 2026, selling an estimated $12K and leaving 749 shares worth $64.5K. The position accounts for 0.02% of the portfolio, ranked #266.

Measured Wealth Private Client Group first reported a position in GMED in Q3 2025 and has held it in 3 quarters since. The position peaked at $77.1K in Q4 2025. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Measured Wealth Private Client Group held 749 shares of Globus Medical worth $64.5K as of Q1 2026.
  • Measured Wealth Private Client Group sold 134 Globus Medical shares in Q1 2026, an estimated $12K.
  • Globus Medical made up 0.02% of Measured Wealth Private Client Group's portfolio in Q1 2026, its #266 holding.
  • Measured Wealth Private Client Group first reported a position in Globus Medical in Q3 2025 and has held it in 3 quarters since.
  • Measured Wealth Private Client Group's Globus Medical position peaked at $77.1K in Q4 2025.
  • 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Measured Wealth Private Client Group's 13F filing for Q1 2026, filed 13 May 2026.